Hypertension and sleep apnea-hypopnea syndrome: changes in echocardiographic abnormalities depending on the presence of hypertension and treatment with CPAP

Sleep Medicine

Volumn 10, Issue 3, 2009, Pages 344-352

  Moro, Jose A ^a   Almenar, Luis ^a   Fernández Fabrellas, Estrella ^b   Ponce, Silvia ^b   Blanquer, Rafael ^b   Salvador, Antonio ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b HOSPITAL UNIVERSITARIO DR PESET   (Spain)

Author keywords

Continuous positive airway pressure; Echocardiography; Hypertension; Sleep apnea syndrome; Ventricular function

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART PERFORMANCE; HEART VENTRICLE FILLING; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; SLEEP APNEA SYNDROME;

ADULT; BLOOD FLOW VELOCITY; CONTINUOUS POSITIVE AIRWAY PRESSURE; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; OBSERVER VARIATION; PREVALENCE; SLEEP APNEA SYNDROMES; STROKE VOLUME; TREATMENT OUTCOME;

EID: 64449085318     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2008.03.008     Document Type: Article

References (40)

1. Young T., Palta M., Dempsey J., Skatrud J., Weber S., and Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328 (1993) 1230-1235
2. Duran J., Esnaola S., Rubio R., and Iztueta A. Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30-70 yr. Am J Respir Crit Care Med 163 (2001) 685-689
3. Spanish Consensus of sleep apnea-hypopnea syndrome. Sleep Spanish Group. Arch Bronconeumol 2005;41(Suppl. 4):51-67.
4. Newman A.B., Nieto F.J., Guidry U., Lind B.K., Redline S., Pickering T.G., et al. Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study. Am J Epidemiol 154 (2001) 50-59
5. Terán J., Alonso M.L., Cordero J., Ayuela J.M., and Monserrat J.M. Sleep apnea-hypopnea syndrome and the heart. Rev Esp Cardiol 59 (2006) 718-724
6. Nieto F.J., Young T.B., Lind B.K., Shahar E., Samet J.M., Redline S., et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study JAMA 283 (2000) 1829-1836
7. Peppard P.E., Young T., Palta M., and Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342 (2000) 1378-1384
8. Young T., Peppard P., Palta M., Hla K.M., Finn L., Morgan B., et al. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 157 (1997) 1746-1752
9. Martínez Garcia M.A., Gómez Aldaraví R., Gil Martínez T., Soler Cataluña J.J., Bernácer Alpera B., and Román Sánchez P. Sleep-disordered breathing in patients with difficult-to-control hypertension. Arch Bronconeumol 42 (2006) 14-20
10. Alchanatis M., Tourkohoriti G., Kosmas E.N., Panoutsopoulos G., Kakouros S., Papadima K., et al. Evidence for left ventricular dysfunction in patients with obstructive sleep apnoea syndrome. Eur Respir J 20 (2002) 1239-1245
11. Hedner J., Ejnell H., and Caidahl K. Left ventricular hypertrophy independent of hypertension in patients with obstructive sleep apnoea. J Hypertens 8 (1990) 941-946
12. Shivalkar B., Van de Heyning C., Kerremans M., Rinkevich D., Verbraecken J., De Backer W., et al. Obstructive sleep apnea syndrome: more insights on structural and functional cardiac alterations, and the effects of treatment with continuous positive airway pressure. J Am Coll Cardiol 47 (2006) 1433-1439
13. Alchanatis M., Paradellis G., Pini H., Tourkohoriti G., and Jordanoglou J. Left ventricular function in patients with obstructive sleep apnoea syndrome before and after treatment with nasal continuous positive airway pressure. Respiration 67 (2000) 367-371
14. Laaban J.P., Pascal-Sebaoun S., Bloch E., Orvoen-Frija E., Oppert J.M., and Huchon G. Left ventricular systolic dysfunction in patients with obstructive sleep apnea syndrome. Chest 122 (2002) 1133-1138
15. Dingli K., Coleman E.L., Vennelle M., Finch S.P., Wraith P.K., Mackay T.W., et al. Evaluation of a portable device for diagnosing the sleep apnoea/hypopnoea syndrome. Eur Respir J 21 (2003) 253-259
16. Chiner E., Arriero J., Signes-Costa J., Marco J., and Fuentes I. Validation of the Spanish version of the Epworth Sleepiness Scale in patients with a sleep apnea syndrome. Arch Bronconeumol 35 (1999) 422-427
17. American Academy of Sleep Medicine. International classification of sleep disorders. Diagnostic and coding manual, 2nd ed. Westchester, Illinois: American Academy of Sleep Medicine; 2005.
18. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo Jr. J.L., et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42 (2003) 1206-1252
19. Lang R. Recommendations for chamber quantification. Eur J Echocardiogr 7 (2006) 79-108
20. Tei C., Nishimura R.A., Seward J.B., and Tajik A.J. Noninvasive Doppler-derived myocardial performance index: correlation with simultaneous measurements of cardiac catheterization measurements. J Am Soc Echocardiogr 10 (1997) 169-178
21. Tei C., Dujardin K.S., Hodge D.O., Bailey K.R., McGoon M.D., Tajik A.J., et al. Doppler echocardiographic index for assessment of global right ventricular function. J Am Soc Echocardiogr 9 (1996) 838-847
22. García-Río F. Sleep apnea syndrome as cause and consequence of congestive heart failure. Med Clin 116 (2001) 312-314
23. Arias M.A., García-Río F., Alonso-Fernández A., and Sánchez A.M. Sleep apnea-hypopnea syndrome and heart failure. Rev Esp Cardiol 60 (2007) 415-427
24. Bonow R.O., and Udelson J.E. Left ventricular diastolic dysfunction as a cause of congestive heart failure. Mechanisms and management. Ann Intern Med 117 (1992) 502-510
25. Fischer M., Baessler A., Hense H.W., Hengstenberg C., Muscholl M., Holmer S., et al. Prevalence of left ventricular diastolic dysfunction in the community. Results from a Doppler echocardiographic-based survey of a population sample. Eur Heart J 24 (2003) 320-328
26. Dursunoglu N., Dursunoglu D., Ozkurt S., Gur S., Ozalp G., and Evyapan F. Effects of CPAP on right ventricular myocardial performance index in obstructive sleep apnea patients without hypertension. Respir Res 7 (2006) 22
27. Lind L., Andren B., and Arnlöv J. The doppler-derived myocardial performance index is determined by both left ventricular systolic and diastolic function as well as by afterload and left ventricular mass. Echocardiography 22 (2005) 211-216
28. Arnlov J., Ingelsson E., Riserus U., Andren B., and Lind L. Myocardial performance index, a Doppler-derived index of global left ventricular function, predicts congestive heart failure in elderly men. Eur Heart J 25 (2004) 2220-2225
29. Brand A., Dollberg S., and Keren A. The prevalence of valvular regurgitation in children with structurally normal hearts: a color Doppler echocardiographic study. Am Heart J 123 (1992) 177-180
30. Klein A.L., Burstow D.J., Tajik A.J., Zachariah P.K., Taliercio C.P., Taylor C.L., et al. Age-related prevalence of valvular regurgitation in normal subjects: a comprehensive color flow examination of 118 volunteers. J Am Soc Echocardiogr 3 (1990) 54-63
31. Dursunoglu N., Dursunoglu D., Özkurt S., Kumur O., Gür S., Kiter G., et al. Effects of CPAP on left ventricular structure and myocardial performance index in male patients with obstructive sleep apnoea. Sleep Med 8 (2007) 51-59
32. McNicholas W.T., and Bonsigore M.R. Management Committee of EU COST ACTION B26. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 29 (2007) 156-178
33. Faccenda J.F., Mackay T.W., Boon N.A., and Douglas N.J. Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 163 (2001) 344-348
34. Pepperell J.C., Ramdassingh-Dow S., Crosthwaite N., Mullins R., Jenkinson C., Stradling J.R., et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 359 (2002) 204-210
35. Haentjens P., Van Meerhaeghe A., Moscariello A., De Weerdt S., Poppe K., Dupont A., et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med 167 (2007) 757-764
36. Alajmi M., Mulgrew A.T., Fox J., Davidson W., Schulzer M., Mak E., et al. Impact of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: a meta-analysis of randomized controlled trials. Lung 185 (2007) 67-72
37. Bazzano L.A., Khan Z., Reynolds K., and He J. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension 50 (2007) 417-423
38. Arias M.A., Garcia-Rio F., Alonso-Fernandez A., Mediano O., Martinez I., and Villamor J. Obstructive sleep apnea syndrome affects left ventricular diastolic function: effects of nasal continuous positive airway pressures in men. Circulation 112 (2005) 375-383
39. Arias M.A., and García-Rio F. Ventricular dysfunction in obstructive sleep apnea-hypopnea syndrome: in search of clinical significance. Rev Esp Cardiol 60 (2007) 569-572
40. Dumesnil J., Gaudreault G., Honos G., and Kingma J. Use of Valsalva maneuver to unmask left ventricular diastolic function abnormalities by Doppler echocardiography in patients with coronary artery disease or systemic hypertension. Am J Cardiol 68 (1991) 515-519